Mary Hayes
Sr. MSL / Field Medical Affairs Director at Enzyvant | Rochester, New York, United States
Engage
candidates 10x faster
Enjoy unlimited access and discover candidates outside of LinkedIn
Trusted by 1.4M users from 76% of Fortune 500 companies
The most accurate data ever
CCPA Compliant
GDPR Compliant
150M
Personal Emails
200M
Work Emails
100M
Direct Dials
250M
Professional Profiles
40M
Company Profiles
Find anyone, anywhere
with ContactOut
today
Making remote or global hires?
Connecting
with key decision-makers? We can help.
- 40 emails / month
- 3 phone numbers / month
- Works on standard LinkedIn only
-
Work emails, personal emails,
mobile numbers
No credit card required
Sr. MSL / Field Medical Affairs Director at Enzyvant in April 2018 to Present
Sr. National Director, Medical Science Liaisons, Medical Affairs at Wellstat Therapeutics Corporation in February 2017 to March 2018
Medical Affairs Consultant (Rare & Orphan Diseases) at BioCentricity Solutions, LLC in May 2014 to February 2017
Director, Global Medical Affairs Knowledge Management at Shire Plc (Rare Diseases) in January 2012 to January 2014
Director, Medical Science Liaison Team, North America at Shire Plc (Rare Diseases) in January 2010 to January 2012
Senior Medical Science Liaison, North East Region, Global Medical Affairs at Shire Plc (Rare Diseases) in January 2009 to January 2010
Director / Manager, Business Development, East Coast at VirtualScopics (Imaging Solutions for Clinical Trials) / Harris Interactive (Healthcare Research) in January 2007 to December 2008
Clinical Liaison, New England Region at Arginox Pharmaceuticals, Inc. in January 2005 to January 2006
Clinical Business Manager at Cubist Pharmaceuticals, Inc. in January 2003 to January 2005
Regional Trainer / Immunology Specialist at InterMune, Inc. in January 2001 to January 2003
Cardiovascular Division Manager / Clinical Research Specialist at Genentech, Inc. in January 1996 to January 2001
See more
See less
Medical Affairs
Oncology
Clinical Development
Clinical Research
Product Launch
Biopharmaceuticals
Pharmaceutical Industry
Biotechnology
Infectious Diseases
Neurology
Cardiology
Therapeutic Areas
Business Strategy
Competitive Intelligence
Cross-functional Team Leadership
Pulmonology
Immunology
Medical Devices
Managed Care
Life Sciences
New Business Development
Enterprise Systems
Securities
See more
See less
Discover more about EnzyvantWhat is Mary Hayes email address?
Email Mary Hayes at [email protected] and [email protected]. This email is the most updated Mary Hayes email found in 2026.
What is Mary Hayes phone number?
Mary Hayes phone number is +15852594475.
How to contact Mary Hayes?
To contact Mary Hayes send an email to [email protected] or [email protected]. If you want to call Mary Hayes try calling on +15852594475. (updated on May 20, 2024)
What company does Mary Hayes work for?
Mary Hayes works for Enzyvant
What is Mary Hayes's role at Enzyvant?
Mary Hayes is Sr. MSL / Field Medical Affairs Director
What industry does Mary Hayes work in?
Mary Hayes works in the Biotechnology Research industry.
Mary Hayes Email Addresses
Mary Hayes Phone Numbers
Get a free list of similar prospects, filtered by title, company, or industry.
Build your Prospect ListPeople like Mary Hayes
Customer Success Manager at Magaya Software
Founder at The Pure Pour
Founder / Event Operations Manager at SunLily Events
Midland County Prosecuting Attorney at Midland County Prosecutors Office
Landman at Digital Land Consultants
Operations Processors 3 at Wells Fargo
Store Manager at Sally Beauty
Maintenance Worker at La Quinta by Wyndham
Director of Account Management at JMI
Enterprise Account Executive at Arctic Wolf
Program Manager & Sales Executive at Gallagher Insurance
Financial Advisor at Investment Planners, Inc. -- IPI Wealth Management, Inc.
Parish Administrator at Holy Apostles Greek Orthodox Church
Assistant Manager at Holiday Stationstores
Call Taker at Falk
Educator at McClure-Hoey Educational Services
Certified Massage Therapist/Owner at Richmond Massage on Main
Director, Cloud - Strategic Investments at BlackLine
Show more
Show less